Protective effect of paeoniflorin against optic nerve crush

Jing Li , Xinchun Xiong , Yunhai Liu

Current Medical Science ›› 2007, Vol. 27 ›› Issue (7) : 650 -652.

PDF
Current Medical Science ›› 2007, Vol. 27 ›› Issue (7) : 650 -652. DOI: 10.1007/s11596-007-0607-y
Article

Protective effect of paeoniflorin against optic nerve crush

Author information +
History +
PDF

Abstract

In order to evaluate the efficacy of traditional paeonia extract paeoniflorin against optic nerve crush, 16 Brown Norway rats were divided into two groups at random, with 8 rats in each group. In paeoniaflorin-treated group, 2 mg paeoniaflorin (total volum: 1 mL) was injected into rat’s peritoneum one time a day for a period of 8 days. Rats in untreated group were given a single dose of vehicle. The optic nerve was crushed by a special forceps for 30 s in the left eye and a sham procedure was performed in the right eye on the 2nd day after the first injection. The retrograde fluorogold labeling of ganglion cells was conducted 5 days after optic nerve crush. The whole retina was flat-mounted thereafter. The ganglion cells that survived the crush were counted under fluorescent microscope by using an automatic counting software. As compared with the contralateral eye, the survival rate of ganglion cells in the left eye increased from 40.22% to 64.53% with a significant difference found between them (t=2.55, P=0.023). The results suggested that the paeonia extract paeoniflorin possessed a protective effect against optic nerve crush.

Keywords

paeoniflorin / optic nerve crush / retina ganglion cell / retrograde labeling

Cite this article

Download citation ▾
Jing Li, Xinchun Xiong, Yunhai Liu. Protective effect of paeoniflorin against optic nerve crush. Current Medical Science, 2007, 27(7): 650-652 DOI:10.1007/s11596-007-0607-y

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

SchuettaufF., NaskarR., VorwerkC. K.. Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors. Invest Ophthalmol Vis Sci, 2000, 41: 4313-4316

[2]

YangH. O., KoW. K., KimJ. Y., et al.. Paeoniflorin: an anti-hyperlipidemic agent from Paeonia lactiflora. Fitoterapia, 2004, 75(1): 45-49

[3]

LiuZ. Q., JiangZ. H., ChanK.. Pharmacokinetic interaction of paeoniflorin and sinomenine: pharmacokinetic parameters and tissue distribution characteristics in rats and protein binding ability in vitro. J Pharmacol Sci, 2005, 99: 381-391

[4]

XiaoL., WangY. Z., LiuJ., et al.. Effects of paeoniflorin on the cerebral infarction, behavioral and cognitive impairments at the chronic stage of transient middle cerebral artery occlusion in rats. Life Sci, 2005, 78: 413-420

[5]

LiuD. Z., XieK. Q., JiX. Q., et al.. Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists. Br J Pharmacol, 2005, 146: 604-611

[6]

YanD., SaitoK., OhmiY., et al.. Paeoniflorin, a novel heat shock protein-inducing compound. Cell Stress Chaperones, 2004, 9: 378-389

[7]

TsaiT. Y., WuS. N., LiuY. C., et al.. Inhibitory action of L-type Ca2+ current by paeoniflorin, a major constituent of peony root, in NG108-15 neuronal cells. Eur J Pharmacol, 2005, 523: 16-24

[8]

ZhangG. Q., HaoX. M., ChenS. Z., et al.. Blockade of paeoniflorin on sodium current in mouse hippocampal CA1 neurons. Acta Pharmacol Sin, 2003, 24: 1248-1252

[9]

HeX., XingD., DingY., et al.. Effects of cerebral ischemia-reperfusion on pharmacokinetic fate of paeoniflorin after intravenous administration of Paeoniae Radix extract in rats. J Ethnopharmacol, 2004, 94: 339-344

AI Summary AI Mindmap
PDF

99

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/